dc.contributor.author | Yerlioğlu, Dilay | |
dc.date.accessioned | 2021-03-05T20:54:49Z | |
dc.date.available | 2021-03-05T20:54:49Z | |
dc.identifier.citation | Yerlioğlu D., "Outcome of treat to target strategy in paediatric patients with Crohn's disease and ulcerative colitis on Infliximab", BSPGHAN Annual Meeting, Oxford, İngiltere, 23 - 25 Ocak 2019, ss.70 | |
dc.identifier.other | av_d66fa644-d4e2-41ba-8923-7332b90a0d89 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/141507 | |
dc.identifier.uri | http://www.baps.org.uk/content/uploads/2018/08/BSPGHAN-Annual-Meeting-2019-Programme-08012019.pdf | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Outcome of treat to target strategy in paediatric patients with Crohn's disease and ulcerative colitis on Infliximab | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.contributor.firstauthorID | 2259223 | |